These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19484406)

  • 1. Cognitive effects of pegylated interferon in individuals with primary brain tumors.
    Dickinson MD; Barr CD; Hiscock M; Meyers CA
    J Neurooncol; 2009 Nov; 95(2):231-237. PubMed ID: 19484406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.
    Fontana RJ; Bieliauskas LA; Lindsay KL; Back-Madruga C; Wright EC; Snow KK; Lok AS; Kronfol Z; Padmanabhan L;
    Hepatology; 2007 May; 45(5):1154-63. PubMed ID: 17465000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
    Shepherd J; Brodin H; Cave C; Waugh N; Price A; Gabbay J
    Health Technol Assess; 2004 Oct; 8(39):iii-iv, 1-125. PubMed ID: 15461877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function does not worsen during long-term low-dose peginterferon therapy in patients with chronic hepatitis C.
    Fontana RJ; Bieliauskas LA; Back-Madruga C; Lindsay KL; Litman HJ; Lok AS; Kronfol Z;
    Am J Gastroenterol; 2010 Jul; 105(7):1551-60. PubMed ID: 20104219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study.
    Hauschild A; Dummer R; Ugurel S; Kaehler KC; Egberts F; Fink W; Both-Skalsky J; Laetsch B; Schadendorf D
    Cancer; 2008 Sep; 113(6):1404-11. PubMed ID: 18615619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.
    Alsaran K; Sabry A; Shaheen N
    Int Urol Nephrol; 2011 Sep; 43(3):865-73. PubMed ID: 20490669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatitis B with interferon and combination therapy.
    Cooksley WG
    Clin Liver Dis; 2004 May; 8(2):353-70. PubMed ID: 15481344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New perspectives in the treatment of viral hepatitis C: pegylated interferon alpha].
    Alric L; Cacoub P
    Rev Med Interne; 2001 Oct; 22(10):922-5. PubMed ID: 11695314
    [No Abstract]   [Full Text] [Related]  

  • 10. Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.
    Egberts F; Gutzmer R; Ugurel S; Becker JC; Trefzer U; Degen A; Schenck F; Frey L; Wilhelm T; Hassel JC; Schadendorf D; Livingstone E; Mauch C; Garbe C; Berking C; Rass K; Mohr P; Kaehler KC; Weichenthal M; Hauschild A
    Ann Oncol; 2011 Jul; 22(7):1667-1674. PubMed ID: 21220519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral dynamics and prediction of response to treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Aguilar Reina J
    Rev Esp Enferm Dig; 2009 Oct; 101(10):665-70. PubMed ID: 19899934
    [No Abstract]   [Full Text] [Related]  

  • 12. Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b.
    Scotto G; Fazio V; Fornabaio C; Tartaglia A; Di Tullio R; Saracino A; Angarano G
    Drugs; 2008; 68(6):791-801. PubMed ID: 18416586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive disturbances observed in chronic hepatitis C patients during pegylated interferon alpha and ribavirin therapy].
    Pawełczyk T; Pawełczyk A; Białkowska J; Jabłkowski M; Strzelecki D; Dworniak D; Rabe-Jabłońska J
    Psychiatr Pol; 2008; 42(6):925-41. PubMed ID: 19441669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study.
    Hassaan SH; Darwish AM; Khalifa H; Ramadan HKA; Hassany SM; Ahmed GK; Moustafa EF
    Int J Psychiatry Med; 2019 Nov; 54(6):424-440. PubMed ID: 31219366
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is the type of pegylated interferon important for response to treatment in patients with chronic hepatitis C infection?].
    Buti M
    Enferm Infecc Microbiol Clin; 2008 Mar; 26(3):125-6. PubMed ID: 18358209
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon.
    Brunetto MR; Oliveri F; Colombatto P; Coco B; Ciccorossi P; Bonino F
    J Hepatol; 2003; 39 Suppl 1():S164-7. PubMed ID: 14708697
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-acting interferon: studies on pegylated interferon].
    Ma H; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):78-9. PubMed ID: 11856520
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognition in hepatitis C patients treated with pegylated interferon.
    Wobrock T; Mihm U; Löhr C; Hofmann WP; Sarrazin C; Zeuzem S; Falkai P
    World J Biol Psychiatry; 2009; 10(4 Pt 3):819-26. PubMed ID: 19995219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation.
    Mukherjee S; Rogge J; Weaver L; Schafer DF
    Transplant Proc; 2003 Dec; 35(8):3042-4. PubMed ID: 14697974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexually transmitted reinfection with a new hepatitis C genotype during pegylated interferon and ribavirin therapy.
    den Hollander JG; Rijnders BJ; van Doornum GJ; van der Ende ME
    AIDS; 2005 Mar; 19(6):639-40. PubMed ID: 15802989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.